antibodies A74880说明书

antibodies A74880说明书

 

Porcine NGAL ELISA Kit (A74880)

 猪NGAL ELISA试剂盒(A74880)

应用范围: 夹心ELISA
分析类型: 三明治(定量)
灵敏度: <0.094 ng / ml
范围: 0.156-10 ng / ml
反应性: 猪的
零件编号: EP0121

 

名称: 猪NGAL ELISA试剂盒
应用范围: 夹心ELISA
分析类型: 三明治(定量)
平台: 微孔板
检测类型: 比色法
灵敏度: <0.094 ng / ml
范围: 0.156-10 ng / ml
复苏: 94%
反应性: 猪的
测定原理: 该猪NGAL ELISA试剂盒是用于定量测定猪NGAL的体外酶联免疫吸附测定。

对NGAL有特异性的抗体已包被在微板上。将标准品和样品吸移到孔中,每个样品中存在的NGAL通过固定的抗体与孔结合。洗涤孔并加入抗NGAL抗体(生物素)。洗去未结合的生物素化抗体后,将结合了HRP的抗生蛋白链菌素移入孔中。在将TMB底物溶液添加到孔中之前,将孔再次洗涤,并且颜色会按结合的NGAL的量成比例出现。终止溶液将颜色从蓝色变为黄色,并在450 nm下测量颜色的强度。

存储: 4°C放置6个月。

图片

使用猪NGAL ELISA试剂盒(EP0121)的代表性标准曲线。

目标

请注意:猪NGAL ELISA试剂盒仅供研究使用。它不适用于诊断或治疗用途。

antagen ATG-NGAL说明书

 

antagen是一家位于波士顿的制药公司,致力于创造细胞系,其终目标是生产治疗癌症等疾病的治疗性抗体。Antagen成立于2012年,已开发出抗体糖工程平台,以满足其研发需求。

人嗜中性粒细胞明胶酶相关脂质运载蛋白(NGAL)XpressCard

Human Neutrophil Gelatinase-Associated

Lipocalin (NGAL) XpressCard

(Cat. #: ATG-NGAL)

50 tests, Cat # ATG-NGAL-50

20 tests, Cat # ATG-NGAL-20

10 tests, Cat # ATG-NGAL-10

 

描述

我们是同型分析套件的供应商!不到3分钟即可获得结果!

NGAL,也称为致癌基因24p3或脂质运载蛋白-2(LCN2)通过螯合铁参与先天免疫,进而限制细菌生长。它在嗜中性粒细胞中表达,在肾脏,前列腺和呼吸道和消化道的上皮细胞中表达水平较低。

在急性肾损伤(AKI)的情况下,NGAL在受伤后2小时内以高水平分泌到血液和尿液中。因为NGAL具有蛋白酶抗性且很小,所以蛋白质很容易在尿液中排泄和检测。AKI患者的NGAL水平与其预后的严重程度相关,可用作AKI的生物标志物。NGAL还可用作慢性肾bing,造影剂肾bing和肾移植等手术的早期诊断。

肾脏健康常见的是血清肌酐。血清肌酐是肾功能的标志物,而NGAL是肾损伤的标志物。NGAL水平是诊断AKI的更和敏感的标志物,而不是血清肌酐水平。事实上,已经证实NGAL尿排泄的增加是由于在通过其他方法检测到任何损伤之前发生的管状改变。因此,监测NGAL水平可减少延迟的AKI诊断和治疗。使用更敏感和特异的标记物可以更早地诊断,正确应对AKI,降低发病率和死亡率。

 

背景

 

NGAL,又称癌基因24p3或脂钙蛋白-2(Lcn 2),通过隔离铁参与天然免疫,从而限制细菌的生长。它在中性粒细胞和低水平的I中表达。 呼吸道和消化道的肾脏、前列腺和上皮。

 

在急性肾损伤(AKI)中,NGAL在伤后2小时内大量分泌到血液和尿液中。由于NGAL对蛋白酶有抵抗力,且体积小,所以蛋白质很容易排出。 在尿液中检测到。AKI患者的NGAL水平与预后的严重程度有关,可作为AKI的生物标志物。NGAL也可以用作早期诊断。 用于慢性肾脏病、造影剂性肾bing和肾移植等手术。

 

肾脏健康常用血清肌酐来衡量。血清肌酐是肾功能的标志,而NGAL是肾脏损伤的标志。NGAL是一个更和敏感的水平。 诊断AKI的标志物高于血清肌酐水平。事实上,尿NGAL排泄的增加已经被证明是由于肾损伤发生之前肾小管的改变。 用其他方法测试。因此,监测NGAL水平可减少延迟AKI的诊断和治疗。使用更敏感和更特异的标记可以更早地诊断,纠正对AK的反应。 降低发病率和死亡率。

试验原理

 

Antagen的中性粒细胞明胶酶相关脂钙蛋白(NGAL)Xpress卡利用免疫层析原理(也称为侧流免疫分析(LFIA)。小鼠抗人NGAL蚂蚁 人体被固定在硝化纤维素膜上作为测试线(T线)在测试装置的测试窗口。当测试样本通过测试装置内的膜组件时,NGAL 在样品中被一种与胶体金结合的抗人NGAL抗体结合,并从样品垫中释放出来。这种抗原抗体复合物在细胞膜上移动得更远。 将其固定在膜上的个抗人NGAL膜上,形成一条彩色带,这证实了检测结果是阳性的。无此c 测试窗口中的着色带表示测试结果为负值。内建控制线(C线)将始终出现在测试窗口中,而不论样品中是否存在NGAL。 .

医]标本收集

 

在通过批准的技术采集样本之前,不需要对病人进行事先的特殊准备。

 

新鲜的晨尿更好。尿液可储存在2-8°C至3天,以防检测延误。长期储存时,将标本在-20°C冷冻3个月,或-70°C冷冻更长时间。 周期.

 

应避免试样反复冻融。

 

不要使用溶血,凝块,污染,脂肪和粘稠/混浊的标本。

 

含有沉淀物或颗粒物质的样品必须离心,清上清液仅用于检测。不要加热灭活样品。

 

测试细节

 

将卡片水平放置。

将100升生物液体直接添加到样品井中。

 

等3到5分钟。

 

后果,结果( result的名词复数 )

 

否:只有控件C行出现。

 

阳性:C线和测试T线均出现,说明NGAL的存在。

 

无效:如果20分钟后没有出现C行,则结果无效。这个测试应该用一个新的装置来重复。

 

敏感,感受性

 

检测灵敏度为NGAL降至50 ng/ml。

贮存

 

在室温下将卡片储存在原来的包装中。本产品从认证日期起稳定18个月。建议不要冷冻带材。

 

程序限制

 

本试验用于人尿中NGAL的定性检测,但不反映NGAL的数量。

 

该测试仅用于研究,不应用于诊断。

 

与所有快速试验一样,确定的临床诊断不应以单一试验的结果为基础,而应在对所有临床发现进行评估之后作出。

 

[医]警惕

 

此试剂盒用于体外研究,应由专业人员处理。

 

在执行测试前仔细阅读说明。

 

遵循标准的实验室程序和生物安全指南,并将所有人体标本作为潜在的传染性处理。在整个过程中戴上手套。

 

当检测程序完成后,在121°C下进行至少20 min的蒸压处理。另外,他们也可以用0.5%次氯酸钠处理1-2小时。

 

货号

品名

规格

品牌

ISO-M6-5

Rapid Mouse Monoclonal Antibody Isotyping Kit-1 (5 tests)

5 tests

antagen

ISO-M6-10

Rapid Mouse Monoclonal Antibody Isotyping Kit-1 (10 tests)

10 tests

antagen

ISO-M6-20

Rapid Mouse Monoclonal Antibody Isotyping Kit-1 (20 tests)

20 tests

antagen

ISO-M8a-5

Rapid Mouse Monoclonal Antibody Isotyping Kit-2 (5 tests)

5 tests

antagen

ISO-M8a-10

Rapid Mouse Monoclonal Antibody Isotyping Kit-2 (10 tests)

10 tests

antagen

ISO-M8a-20

Rapid Mouse Monoclonal Antibody Isotyping Kit-2 (20 tests)

20 tests

antagen

ISO-M8c-5

Rapid Mouse Monoclonal Antibody Isotyping Kit-3 (5 tests)

5 tests

antagen

ISO-M8c-10

Rapid Mouse Monoclonal Antibody Isotyping Kit-3 (10 tests)

10 tests

antagen

ISO-M8c-20

Rapid Mouse Monoclonal Antibody Isotyping Kit-3 (20 tests)

20 tests

antagen

ISO-M8ac-5

Rapid Mouse Monoclonal Antibody Isotyping Kit-4 (5 tests)

5 tests

antagen

ISO-M8ac-10

Rapid Mouse Monoclonal Antibody Isotyping Kit-4 (10 tests)

10 tests

antagen

ISO-M8ac-20

Rapid Mouse Monoclonal Antibody Isotyping Kit-4 (20 tests)

20 tests

antagen

ISO-R8-5

Rapid Rat Monoclonal Antibody Isotyping Kit (5 tests)

5 tests

antagen

ISO-R8-10

Rapid Rat Monoclonal Antibody Isotyping Kit (10 tests)

10 tests

antagen

ISO-R8-20

Rapid Rat Monoclonal Antibody Isotyping Kit (20 tests)

20 tests

antagen

ISO-HAM-10

Rapid Hamster Monoclonal Antibody Isotyping Kit (10 tests)

10 tests

antagen

ISO-HAM-20

Rapid Hamster Monoclonal Antibody Isotyping Kit (20 tests)

20 tests

antagen

ATG-LT-01-6

Lentivirus Titration XpressCard (6 tests)

6 tests

antagen

ATG-LT-01-10

Lentivirus Titration XpressCard (10 tests)

10 tests

antagen

ATG-LT-01-20

Lentivirus Titration XpressCard (20 tests)

20 tests

antagen

ATG-LT-01-50

Lentivirus Titration XpressCard (50 tests)

50 tests

antagen

ATG-LT-02-5

LentiTitre Cassette (5 cassettes)

5 tests

antagen

ATG-LT-02-10

LentiTitre Cassette (10 cassettes)

10 tests

antagen

ATG-fFN-10

Human Fetal Fibronectin XpressCard (10 tests)

10 tests

antagen

ATG-NGAL-10

Human Neutrophil Gelatinase-Associated Lipocalin (NGAL) XpressCard (10 tests)

10 tests

antagen

ATG-IL-8-10

Rapid Human Interleukin-8 XpressCard (10 tests)

10 tests

antagen

ATG-IL-8-20

Rapid Human Interleukin-8 XpressCard (20 tests)

20 tests

antagen

ATG-IL-8-50

Rapid Human Interleukin-8 XpressCard (50 tests)

50 tests

antagen

RKL001

LARGE-TEST-TUBE ICEMAN-RACK

ea

antagen

RKS001

SMALL-TEST-TUBE ICEMAN-RACK

ea

antagen

RKP096

96-WELL-PCR-PLATE ICEMAN-RACK

96-WELL

antagen

RKP384

384-WELL-PCR-PLATE RACK

384-WELL

antagen

RKSS01

SMALL-TEST-TUBE-STRIP RACK

ea

antagen

 

 

 

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

 

 

 

NGAL (human) ELISA kit 肾损伤标志物 NGAL 检测试剂盒

NGAL (human) ELISA kit
肾损伤标志物 NGAL 检测试剂盒

  • 产品特性
  • 相关资料
  • Q&A
  • 参考文献

NGAL (human) ELISA kitNGAL (human) ELISA kit                              肾损伤标志物 NGAL 检测试剂盒

肾损伤标志物 NGAL 检测试剂盒

急性肾损伤(Acute Kidney Injury,AKI)是一组临床综合征,以急性肾功能(Acute Renal Failure,ARF)减退为特征。针对 AKI 的诊断及研究,已证实存在于血液或尿液中的多种蛋白可成为肾损伤、肾疾病或肾毒性诊断及愈后的标志物。

其中,中性粒细胞明胶酶相关脂质运载蛋白(NGAL,lipocalin-2,siderocalin)是一种 25 kDa 的小蛋白,在全身上皮组织中表达。其可作为肾损伤标志物,当肾小管损伤后,NGAL 可从患者的尿液和血液中检出。

NGAL(人)ELISA 试剂盒,可在 450 nm 处高灵敏度检测人样本中 NGAL,低至 4 pg/mL。

 

特点

● 96 孔板检测,只需 4 小时即可快速检测最多 40 个样品及其平行组

● 高灵敏检测,可检测低至 4 pg/mL 的 NGAL

● 试剂盒包含即用型预涂板和独立标准溶液,可节省时间并减少操作失误

● 全定量分析,有别于半定量分析的免疫印迹法

◆NGAL(人)ELISA试剂盒(KIT 036)- 标准曲线

NGAL (human) ELISA kit                              肾损伤标志物 NGAL 检测试剂盒

◆产品详情

NGAL别称

中性粒细胞明胶酶相关脂质运载蛋白、脂质运载蛋白2、铁运载蛋白、癌基因产物24p3

灵敏度

4 pg/mL(范围10-1000 pg/mL)

检测时间

小于4小时

应用

ELISA、比色检测

应用说明

用于定量检测人尿液、血浆、血清、组织提取物和培养上清液中的NGAL

波长

450 nm

物种反应性

运输条件

非冷冻蓝冰

长期储存

+4°C

组分

1. 12 × 8 孔微孔板条,每条均涂有抗 NGAL抗体(共96孔)+板条框

2. 样品稀释液

3. NGAL标准溶液1-8:0,10,25,50,100,250,500,1000 pg/mL

4. 25X浓缩洗涤液

5. 生物素化 NGAL 抗体

6. HRP-链霉亲和素偶联物

7. TMB底物

8. 终止液

技术信息/产品说明

点击此处查看操作手册

UniProt ID

P80188

监管状态

RUO – 仅供研究用

制造商

BioPorto Diagnostics

◆产品列表

产品编号

产品名称

包装

BPD-KIT-036

NGAL (human) ELISA kit
NGAL(人)ELISA试剂盒

96 wells




◆其他物种的 NGAL 试剂盒

除NGAL (人) ELISA试剂盒外,另可提供小鼠、大鼠、猪、狗、猴的 NGAL ELISA 试剂盒。

NGAL (human) ELISA kit                              肾损伤标志物 NGAL 检测试剂盒

产品编号

产品名称

包装

BPD-KIT-042

NGAL (mouse) ELISA kit
NGAL(小鼠)ELISA试剂盒

96 wells

BPD-KIT-043

NGAL (dog) ELISA kit
NGAL(狗)ELISA试剂盒

96 wells

BPD-KIT-044

NGAL (pig) ELISA kit
NGAL(猪)ELISA试剂盒

96 wells

BPD-KIT-045

NGAL (monkey) ELISA kit
NGAL(猴)ELISA试剂盒

96 wells

BPD-KIT-046

NGAL (rat) ELISA kit
NGAL(大鼠)ELISA试剂盒

96 wells

 

参考文献

1.

The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males: T. Tominaga, et al.; Antioxidants (Basel) 10, 866 (2021), Application(s): NGAL quantification on human urine samples, 摘要全文


2.

Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease: F.S. Seibert, et al.; Kidney Blood Press. Res. 43, 1255 (2018), Application(s): ELISA using human urine, 摘要;


3.

Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study: J. Metzger, et al.; Crit. Care 20, 157 (2016), 摘要全文


4.

An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions: J. Kanda, et al.; Clin. Exp. Nephrol. 19, 99 (2015), 摘要;


5.

Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections: R. Barreto, et al.; J. Hepatol. 61, 35 (2014), Application(s): ELISA using human urine, 摘要;


6.

A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine: R.L. Kift, et al.; Ann. Clin. Biochem. 50, 236 (2013), 摘要;


7.

Albumin oxidation leads to neutrophil activation in vitro and inaccurate measurement of serum albumin in patients with diabetic nephropathy: R. Michelis, et al.; Free Radic. Biol. Med. 60, 49 (2013), 摘要;


8.

Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxia: K. Murase, et al.; PLoS One 8, e54184 (2013), 摘要;


9.

BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool?: S. Rau, et al.; Clin. Transplant. 27, E184 (2013), 摘要;


10.

Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?: A. Lacquaniti, et al.; Radiology 267, 86 (2013), 摘要;


11.

Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia: S.M. Kim, et al.; Reprod. Sci. 20, 1083 (2013), 摘要;


12.

Day-to-day variation of urinary NGAL and rational for creatinine correction: J. Helmersson-Karlqvist, et al.; Clin. Biochem. 46, 70 (2013), 摘要;


13.

Differential expression of cancer-associated proteins in breastmilk: W. Qin, et al.; Breastfeed Med. 8, 120 (2013), 摘要;


14.

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury: K. Kashani, et al.; Crit. Care 17, R25 (2013), 摘要;


15.

Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study: M. Di Nardo, et al.; Blood Purif. 35, 172 (2013), 摘要;


16.

Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer: J. Martí, et al.; World J. Surg. 37, 1103 (2013), 摘要;


17.

Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial: M. Haase, et al.; PLoS Med. 10, e1001426 (2013), 摘要;


18.

Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants: H. Inoue, et al.; Early Hum. Dev. 89, 425 (2013), 摘要;


19.

The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury: J.W. Pickering, et al.; Blood Purif. 35, 295 (2013), 摘要;


20.

The role of urinary liver-type fatty acid-binding protein in critically ill patients: E. Cho, et al.; J. Korean Med. Sci. 28, 100 (2013), 摘要;


21.

Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation: M. Park, et al.; Biomark. Insights 8, 15 (2013), 摘要;


22.

Albuminuria increases cystatin C excretion: implications for urinary biomarkers: M. Nejat, et al.; Nephrol. Dial. Transplant. 27 Suppl 3, iii96 (2012), 摘要;


23.

Are serum and urine neutrophil gelatinase-associated lipocalin predictive of renal graft function in short term?: N. Rahimzadeh, et al.; Pediatr. Transplant. 16, 796 (2012), 摘要;


24.

Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure: K. Shrestha, et al.; Congest. Heart Fail. 18, 239 (2012), 摘要;


25.

Delayed graft function (DGF) after living donor kidney transplantation: a study of possible explanatory factors: J. Salamzadeh, et al.; Ann. Transplant. 17, 69 (2012), 摘要;


26.

Evaluation of the impact of shock wave lithotripsy on kidneys using a new marker: how do neutrophil gelatinese-associated lypocalin values change after shock wave lithotripsy?: F. Zekey, et al.; Urology 80, 267 (2012), 摘要;


27.

Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study: K.R. Pedersen, et al.; J. Thorac. Cardiovasc. Surg. 143, 576 (2012), 摘要;


28.

Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study: K.R. Pedersen, et al.; J. Thorac. Cardiovasc. Surg. 143, 576 (2012), 摘要;


29.

Mild elevation of urinary biomarkers in prerenal acute kidney injury: K. Doi, et al.; Kidney Int. 82, 1114 (2012), 摘要;


30.

Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation: T.D. Jeong, et al.; Clin. Transplant. 26, 775 (2012), 摘要;


31.

Renal function and solitary kidney disease: Wilms tumour survivors versus patients with unilateral renal agenesis: J. Stefanowicz, et al.; Kidney Blood Press. Res. 35, 174 (2012), 摘要;


32.

Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease: N. Kafkas, et al.; Int. J. Inflam. 2012, 189797 (2012), 摘要;


33.

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study: S.E. Nielsen, et al.; Diabet. Med. 29, e184 (2012), 摘要;


34.

The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP: S.E. Nielsen, et al.; Scand J. Clin. Lab Invest. 72, 137 (2012), 摘要;


35.

Urinary markers of kidney injury and kidney function decline in HIV-infected women: M.G. Shlipak, et al.; J. Acquir. Immune Defic. Syndr. 61, 565 (2012), 摘要;


36.

Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients: N. Heyne, et al.; Transplantation 93, 1252 (2012), 摘要;


37.

Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants: V. Tosse, et al.; Neonatology 101, 260 (2012), 摘要;


38.

Clinical outcome of renal tubular damage in chronic heart failure: K. Damman, et al.; Eur. Heart J. 32, 2705 (2011), 摘要;


39.

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function: Z.H. Endre, et al.; Kidney Int. 79, 1119 (2011), 摘要;


40.

Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome: C.G. Jungbauer, et al.; Eur. J. Heart. Fail. 13, 1104 (2011), 摘要;


41.

KIM-1 and NGAL: new markers of obstructive nephropathy: A. Wasilewska, et al.; Pediatr. Nephrol. 26, 579 (2011), 摘要;


42.

Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics: B.C. te Boekhorst, et al.; Cardiovasc. Res. 89, 680 (2011), 摘要;


43.

Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients: H.R. H. de Geus, et al.; Am. J. Respir. Crit. Care Med. 183, 907 (2011), 摘要;


44.

Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass: C.D. Krawczeski, et al.; J. Pediatr. 158, 1009 (2011), 摘要;

45.

Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure: K. Shrestha, et al.; J. Card. Fail. 17, 472 (2011), 摘要;


46.

Serum neutrophil gelatinase-associated lipocalin – a sensitive novel marker of renal impairment in liver cirrhosis?: A.L. Gerbes, et al.; Digestion 84, 82 (2011), 摘要;

47.

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass: C.D. Krawczeski, et al.; J. Am. Coll. Cardiol. 58, 2301 (2011), 摘要;


48.

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy: S.E. Nielsen, et al.; Kidney Int. 79, 1113 (2011), 摘要;


49.

Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study: S.E. Nielsen, et al.; Nephron Clin. Pract. 118, c130 (2011), 摘要;


50.

Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation: G. Wagener, et al.; Nephrol. Dial. Transplant. 26, 1717 (2011), 摘要;


51.

Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants: G. La Manna, et al.; Pediatr. Res. 70, 379 (2011), 摘要;


52.

Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function: K. Damman, et al.; J. Am. Coll. Cardiol. 57, 2233 (2011), 摘要;


53.

Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage: J.M. Sheen, et al.; J. Pediatr. Surg. 45, 1650 (2010), 摘要;


54.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril: S.E. Nielsen, et al.; Diabet. Med. 27, 1144 (2010), 摘要;


55.

Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA: K.R. Pedersen, et al.; Scand J. Clin. Lab Invest. 70, 374 (2010), 摘要;


56.

Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis: Y. Wu, et al.; Clin. J. Am. Soc. Nephrol. 5, 1954 (2010), 摘要;


57.

Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients: J. Malyszko, et al.; Nephron Clin. Pract. 115, c268 (2010), 摘要;


58.

Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy: E. Eisenhart, et al.; Semin. Dial. 23, 638 (2010), 摘要;


59.

Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients: P. Przybylowski, et al.; Transplant Proc. 42, 1797 (2010), 摘要;


60.

Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis: T. Rubinstein, et al.; Rheumatology (Oxford) 49, 960 (2010), 摘要;


61.

Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis: Y. Wu, et al.; Am. J. Med. Sci. 339, 537 (2010), 摘要;


62.

Urinary neutrophil-gelatinase associated lipocalin is a potential noninvasive marker for renal scarring in patients with vesicoureteral reflux: M. Ichino, et al.; J. Urol. 183, 2001 (2010), 摘要;


63.

Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury: H.N. Yang, et al.; Am. J. Nephrol. 31, 501 (2010), 摘要;


64.


Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis: M. Katano, et al.; Arthritis Res. Ther. 11, R3 (2009), 摘要;


65.

NGAL: a new missing link between inflammation and uremic anemia?: D. Bolignano, et al.; Ren. Fail. 31, 622 (2009), 摘要;


66.

Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients: J. Boldt, et al.; Br. J. Anaesth. 100, 457 (2008), 摘要;


67.

Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function: D. Bolignano, et al.; J. Investig. Med. 56, 997 (2008), 摘要;


68.

Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL: G. Wagener, et al.; Am. J. Nephrol. 28, 576 (2008), 摘要;


69.

Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis: M. Suzuki, et al.; Pediatr. Nephrol. 23, 403 (2008), 摘要;


70.

Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia: C. Villalva, et al.; Leuk. Lymphoma 49, 984 (2008), 摘要;


71.

Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease: D. Bolignano, et al.; Kidney Blood Press. Res. 31, 255 (2008), 摘要;


72.


NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?: H. Bachorzewska-Gajewska, et al.; Int. J. Cardiol. 127, 290 (2008), 摘要;


73.

NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?: H. Bachorzewska-Gajewska, et al.; Int. J. Cardiol. 127, 290 (2008), 摘要;

74.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease: J. Malyszko, et al.; Ren. Fail. 30, 625 (2008), 摘要;


75.

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure: K. Damman, et al.; Eur. J. Heart Fail. 10, 997 (2008), 摘要;


76.

Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients: D. Bolignano, et al.; Nephrol. Dial. Transplant. 23, 414 (2008), 摘要;


77.

Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: G. Wagener, et al.; Am. J. Kidney Dis. 52, 425 (2008), 摘要;


78.

Urinary NGAL in premature infants: A.P. Lavery, et al.; Pediatr. Res. 64, 423 (2008), 摘要;


79.

Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery: C. Xin, et al.; Ren. Fail. 30, 904 (2008), 摘要;


80.

Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study: M. Bennett, et al.; Clin. J. Am. Soc. Nephrol. 3, 665 (2008), 摘要;


81.


Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?: H. Bachorzewska-Gajewska, et al.; Kidney Blood Press. Res. 30, 408 (2007), 摘要;


82.

Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology: S. Schaub, et al.; Transplantation 84, 104 (2007), 摘要;


83.

Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography: H. Bachorzewska-Gajewska, et al.; Nephrol. Dial. Transplant. 22, 295 (2007), 摘要;


84.

Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease: D. Bolignano, et al.; Am. J. Nephrol. 27, 373 (2007), 摘要;


85.

Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions: H. Bachorzewska-Gajewska, et al.; Am. J. Nephrol. 26, 287 (2006), 摘要;


其他参考文献

1.


Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics: D. Burt, et al.; Drug Chem. Toxicol. 37, 204 (2014), 摘要;